UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in shares of agilon health, inc. (NYSE:AGL - Free Report) by 24.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 797,658 shares of the company's stock after buying an additional 157,610 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned approximately 0.19% of agilon health worth $1,516,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Two Sigma Advisers LP raised its position in agilon health by 4,393.5% in the 4th quarter. Two Sigma Advisers LP now owns 480,800 shares of the company's stock valued at $914,000 after buying an additional 470,100 shares during the last quarter. Two Sigma Investments LP grew its stake in agilon health by 73.7% in the fourth quarter. Two Sigma Investments LP now owns 857,867 shares of the company's stock valued at $1,630,000 after purchasing an additional 363,855 shares in the last quarter. State of Wyoming grew its stake in agilon health by 89.3% in the fourth quarter. State of Wyoming now owns 122,504 shares of the company's stock valued at $233,000 after purchasing an additional 57,802 shares in the last quarter. Point72 Asset Management L.P. bought a new position in shares of agilon health during the 4th quarter worth approximately $768,000. Finally, ProShare Advisors LLC boosted its stake in shares of agilon health by 49.0% during the 4th quarter. ProShare Advisors LLC now owns 86,881 shares of the company's stock worth $165,000 after acquiring an additional 28,586 shares during the period.
Wall Street Analyst Weigh In
Several brokerages have recently commented on AGL. Citigroup upgraded agilon health from a "neutral" rating to a "buy" rating and lifted their target price for the stock from $3.25 to $5.00 in a research note on Friday, April 25th. JMP Securities restated a "market perform" rating on shares of agilon health in a research note on Monday, April 28th. Stifel Nicolaus boosted their price target on agilon health from $2.00 to $3.00 and gave the company a "hold" rating in a research note on Wednesday, February 26th. Robert W. Baird reduced their price target on agilon health from $6.00 to $5.00 and set a "neutral" rating for the company in a research note on Tuesday, April 15th. Finally, The Goldman Sachs Group boosted their price target on agilon health from $2.50 to $5.00 and gave the company a "neutral" rating in a research note on Thursday, May 8th. Two research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and five have given a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus target price of $4.79.
Check Out Our Latest Stock Report on AGL
agilon health Price Performance
Shares of agilon health stock traded up $0.01 during trading on Wednesday, reaching $2.29. 3,080,748 shares of the company's stock were exchanged, compared to its average volume of 4,976,370. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. agilon health, inc. has a 1-year low of $1.50 and a 1-year high of $7.73. The company has a market cap of $945.88 million, a P/E ratio of -2.43 and a beta of 0.14. The firm's 50-day moving average price is $3.46 and its 200 day moving average price is $3.20.
agilon health (NYSE:AGL - Get Free Report) last issued its earnings results on Tuesday, May 6th. The company reported $0.03 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.01) by $0.04. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The business had revenue of $1.53 billion during the quarter, compared to analysts' expectations of $1.50 billion. During the same quarter in the prior year, the firm earned ($0.02) EPS. The business's revenue for the quarter was down 4.5% compared to the same quarter last year. As a group, research analysts anticipate that agilon health, inc. will post -0.59 earnings per share for the current year.
agilon health Company Profile
(
Free Report)
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Featured Stories

Before you consider agilon health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.
While agilon health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.